Vivace Therapeutics
PrivateLast Round
Series D
Mar 12, 2025
Est. Valuation
$125M
Total Funding Raised
$105M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vivace Therapeutics is a biotechnology company that develops small molecule cancer therapies targeting the Hippo-YAP signaling pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivace Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vivace Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 12, 2025 | ||||
| Series C | Dec 16, 2020 | ||||
| Series B | Jun 28, 2017 | ||||
| Series A | Jan 20, 2015 |
Vivace Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series D |
| Boxer Capital | Series C |
| BioInnovation Capital | Series B |
| WuXi Healthcare Ventures | Series B, Series A |
| Sequoia Capital | Series C |
| Cenova Capital | Series C, Series D, Series B |
| HongShan | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 49% MoM.
- Mar 12, 2025
$35M round completed.
Vivace Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivace Therapeutics's valuation, stock price, and market status.